To determine the efficacy of anti-tumor necrosis factor therapy (etanercept) for treating endometriosis in the rat endometriosis model.
A randomized, placebo-controlled, blinded study using rat endometriosis model. After the peritoneal implantation of endometrial tissue, twenty-eight Wistar female rats were randomized to two equal intervention groups: the control group and the etanercept-treated group. After measuring implant volume, pretreatment blood and peritoneal fluid samples were obtained. A vehicle treatment of 2 mL saline to the rats in control group and 0. 4 mg/kg etanercept SC once weekly were administered in the etanercept-treated group. After four weeks treatment period, the volumes and histopathological properties of the implants were evaluated. A scoring system was used to evaluate preservation of epithelia. Endometrial explants were evaluated immunohistochemically for tumor necrosis factor receptor type 2 (TNFR2). A scoring system was used to evaluate expression grade of TNFR2.
There was not a significant difference in spherical volume between control (131.0 (60.3–501.2)) and treatment groups (72.8 (31.2–149.6)) (p > 0.025). There was a significant change in between the volumes of implants before and after treatment in etanercept group (p < 0.05). At the end of the treatment significant differences among the groups were found in histopathological and immunohistochemical parameters (p < 0.05) also histologic scores and HSCORES were decreased in the treatment group significantly (p < 0.05).
These results indicate that etanercept was found to effectively reduce the development of endometriosis in this experimental rat model.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Obstetrics and Gynecology and Reproductive Biology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Endometriosis is sustained by tumour necrosis factor alpha.Med Hypotheses. 2003; 60: 84-88
- Effects of anti-TNF-mAb treatment on pregnancy in baboons with induced endometriosis.Fertil Steril. 2008; 89: 1537-1545
- Regression of endometrial explants in a rat model of endometriosis treated with melatonin.Fertil Steril. 2008; 89: 934-942
- Immunology of endometriosis.Immunol Allergy Clin North Am. 2002; 22: 585-598
- The role of cytokines in endometriosis.Am J Reprod Immunol. 2003; 49: 285-296
- Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study.Biol Reprod. 2006; 74: 131-136
- Immunobiology of endometriosis.Fertil Steril. 2001; 75: 1-10
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial.Hum Reprod. 2002; 17: 426-431
- Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis.Arch Gynecol Obstet. 2005; 271: 143-147
- Effect of tumor necrosis factor alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system.Fertil Steril. 1993; 59: 1196-1201
- Stimulation of prostaglandin (PG) F2 alpha and PGE2 release by tumour necrosis factor-alpha and interleukin-1 alpha in cultured human luteal phase endometrial cells.Hum Reprod. 1995; 10: 2773-2780
- Mechanisms of excessive estrogen formation in endometriosis.J Reprod Immunol. 2002; 55: 21-33
- Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.Placenta. 2009; 30: 111-123
- Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up.Fertil Steril. 1993; 59: 511-515
- Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons.Fertil Steril. 2004; 81: 775-779
- Recombinant human TNF binding protein-1 (r-h TBP-1) inhibits the development of endometriosis in baboons: a prospective randomized, placebo- and drug-controlled study.Fertil Steril. 2001; : 76-81
- Ability of recombinant human TNF binding protein-1 (r- hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats.J Reprod Immunol. 2000; 48: 81-98
- Tumour necrosis factor inhibitors.Med J Aust. 2005; 183: 205-208
- Studies on the surgical induction of endometriosis in the rat.Fertil Steril. 1985; 44: 684-694
- Leflunomide-an immunomodulator induces regression of endometrial explants in a rat model of endometriosis.J Soc Gynecol Investig. 2006; 13: 378-383
- Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole.Fertil Steril. 1999; 72: 135-141
- Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.Arch Pathol Lab Med. 1985; 109: 716-721
- Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.Cancer Res. 1986; 46: 5419-5425
- Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells.Fertil Steril. 1997; 67: 1065-1072
- Endometrial apoptosis is inhibited invitro by TNF-α in healthy women.J Soc Gynecol Investig. 2000; 47: 218A
- Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract.Am J Reprod Immunol. 1998; 39: 209-216
- Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture.Fertil Steril. 1993; 60: 839-851
- Experimental endometriosis in laboratory animals as a research model.Prog Clin Biol Res. 1990; 323: 49-60
- Tumour necrosis factor-alpha blockers: potential limitations in the management of advanced endometriosis? A case report.Hum Reprod. 2006; 21: 2417-2420
Published online: June 27, 2011
Accepted: June 9, 2011
Received in revised form: April 3, 2011
Received: March 8, 2010
© 2011 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.